StockTake: EMVision expands trial for bedside stroke scanner

Stockhead’s Tylah Tully looks at the latest from EMvision Medical Devices (ASX:EMV), who have increased the sites for its pivotal trial for the emu bedside brain scanner, a device designed to rapidly diagnose stroke.

Watch the video for more.

This video was developed in collaboration with EMvision Medical Devices, a Stockhead advertiser at the time of publishing.

This video does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.